Stanley-Laman »

Corcept Therapeutics Incorporated shares owned by Stanley-Laman

Quarter-by-quarter ownership of Corcept Therapeutics Incorporated (CORT) shares owned by Stanley-Laman from 13F filings

Historical chart of Stanley-Laman investment in Corcept Therapeutics Incorporated

Tip: Access up to 7 years of quarterly data

All positions including Corcept Therapeutics Incorporated held by Stanley-Laman consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Corcept Therapeutics Incorporated by Stanley-Laman

Quarter filed Position value Share count Share price at filing
2025-09-30 $2.0M 25k 83.11

More positions owned by Stanley-Laman

Microsoft Corporation (MSFT)
Alphabet Inc Class Class A Cap Stk Cl A (GOOGL)
Amazon (AMZN)
NVIDIA Corporation (NVDA)
Asml Hldg N V F Sponsored Adr 1 Adr Reps 1 Ord N Y Registry Shs (ASML)
Cameco Corporation (CCJ)
Broadcom (AVGO)
Raytheon Technologies Corp (RTX)
Meta Platforms Inc Class A Cl A (META)
Apple (AAPL)
Arista Networks Com Shs (ANET)
Lam Resh Corp Com New (LRCX)
Linde
Taiwan Semiconductor M F Sponsored Adr 1 Adr Reps 5 Ord Sponsored Adr (TSM)
Monolithic Power Systems (MPWR)

View all positions for Stanley-Laman

Top funds holding Corcept Therapeutics Incorporated

BlackRock
Vanguard Group
Ingalls & Snyder
Renaissance Technologies
Parallel Advisors
State Street Corporation
FMR
Geode Capital Management
Dimensional Fund Advisors
Morgan Stanley
AQR Capital Management
ClearBridge Advisors
Charles Schwab Investment Management
TD Asset Management
Jpmorgan Chase & Co

View all funds holding Corcept Therapeutics Incorporated